Cerivastatin Sodium
Generic Name: cerivastatin sodium
Manufactured by BAYER PHARMS. Dosage form: TABLET. Route: ORAL. Active ingredients: CERIVASTATIN SODIUM (0.2MG). Application: NDA020740.
Overview
Manufactured by BAYER PHARMS. Dosage form: TABLET. Route: ORAL. Active ingredients: CERIVASTATIN SODIUM (0.2MG). Application: NDA020740.
Dosage
Available as tablet for oral use.
Related Medications
Calcitonin Salmon Recombinant
calcitonin salmon recombinant
Manufactured by UPSHER SMITH LABS. Dosage form: SPRAY, METERED. Route: NASAL. Active ingredients: CALCITONIN SALMON RECOMBINANT (200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA021406.
Ferr Phos, Kali Mur, Kali Phos, Mag Phos
ferr phos, kali mur, kali phos, mag phos
Uses Temporarily relieves occasional watery and loose stools, mucus discharge, a consistent urge to empty the bowels, and/or painful bowel movements.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Durvalumab
durvalumab
Programmed Death Ligand-1 Blocker [EPC]
11 DESCRIPTION Durvalumab is a programmed cell death ligand 1 (PD-L1) blocking antibody. Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that is produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture. IMFINZI (durvalumab) Injection for intravenous use is a sterile, preservative-free, clear to opalescent, colorless to slightly yellow solution, free from visible particles.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.